Click image to view it in full size

The Tissue Diagnostics (TDx) market is expected to reach $8.8 billion in 2025, growing at a CAGR of 8% from 2019. Advanced Staining and Anatomical Pathology Laboratory Information Management Systems (APLIS) will continue to grow at higher rates due to growing demand for personalized diagnosis and need for automation respectively. The top 5 companies together had a combined accounted for 69% of the global IVD revenue for 2020. Given the market dynamics, trends and competitive nature, it is important to get an overall perspective on the technology segments as well as workflow. This report offers insightful analysis in the form of overall forecast, region and technology segment-wise analysis, benchmarking of top participants, and key growth opportunities.

The change in reimbursement structure for diagnostic testing, regulatory trends in Europe, demand for large scale testing, transition to companion diagnostics, shrinking pathology workforce, emerging companies and evolving business models demand assessing portfolio, evaluating competitor strategies and exploring opportunities for business growth. Over the years, the competitive nature of the Tissue Diagnostics industry has showcased a high traction due to growing cancer prevalence globally and the need to facilitate early diagnosis. Advanced staining and Anatomical Pathology Laboratory Information Management Systems (APLIS) dominates the market share while pre-analytical staining recorded a low growth and may continue to observe a stagnant market. The top 5 companies together had a combined accounted for 69% of the global IVD revenue for 2020. This report offers insightful analysis in the form of overall forecast, region and technology segment-wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry.